Real-time enrollment status for this lung cancer clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 7:18 AM UTC
| NCT Number | NCT05800015 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Lung Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 950 participants |
| Active Locations | 30 sites in the US |
| Sponsor | Regeneron Pharmaceuticals |
| Last Updated on CT.gov | January 22, 2026 (Jan 22, 2026) |
As of March 2, 2026: Clinical trial NCT05800015 is currently active_not_recruiting participants. This clinical trial study for lung cancer is not currently accepting new participants at 30 locations across the United States. The study is sponsored by Regeneron Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05800015 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 30 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05800015 was last updated Jan 22, 2026 (January 22, 2026). HelloStudys verifies this status automatically.